Diazirines. 3. Synthesis of a series of diazirine-containing molecules and their pharmacological evaluation.
D000700:Analgesics / Q000138:chemical synthesis / Q000494:pharmacology; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000138:chemical synthesis / Q000494:pharmacology; D000928:Antidepressive Agents / Q000138:chemical synthesis / Q000494:pharmacology; D000959:Antihypertensive Agents / Q000138:chemical synthesis / Q000494:pharmacology; D001389:Azirines / Q000138:chemical synthesis* / Q000494:pharmacology; D001522:Behavior, Animal / Q000187:drug effects; D001786:Blood Glucose / Q000032:analysis; D001794:Blood Pressure / Q000187:drug effects; D004231:Diuresis / Q000187:drug effects; D004232:Diuretics / Q000138:chemical synthesis / Q000494:pharmacology; D004285:Dogs; D007004:Hypoglycemic Agents / Q000138:chemical synthesis / Q000494:pharmacology; D008297:Male; D051379:Mice; D051381:Rats; D013329:Structure-Activity Relationship
D000700:Analgesics; D000893:Anti-Inflammatory Agents; D000928:Antidepressive Agents; D000959:Antihypertensive Agents; D001389:Azirines; D001786:Blood Glucose; D004232:Diuretics; D007004:Hypoglycemic Agents